Search by Drug Name or NDC
NDC 70954-0159-30 Clorazepate Dipotassium 3.75 mg/1 Details
Clorazepate Dipotassium 3.75 mg/1
Clorazepate Dipotassium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is CLORAZEPATE DIPOTASSIUM.
Product Information
| NDC | 70954-0159 |
|---|---|
| Product ID | 70954-159_23835ed6-9802-4fb5-88ef-bef2655db16c |
| Associated GPIs | 57100030100305 |
| GCN Sequence Number | 003745 |
| GCN Sequence Number Description | clorazepate dipotassium TABLET 3.75 MG ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 14092 |
| HICL Sequence Number | 001612 |
| HICL Sequence Number Description | CLORAZEPATE DIPOTASSIUM |
| Brand/Generic | Generic |
| Proprietary Name | Clorazepate Dipotassium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clorazepate Dipotassium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 3.75 |
| Active Ingredient Units | mg/1 |
| Substance Name | CLORAZEPATE DIPOTASSIUM |
| Labeler Name | ANI Pharmaceuticals, Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA213730 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70954-0159-30 (70954015930)
| NDC Package Code | 70954-159-30 |
|---|---|
| Billing NDC | 70954015930 |
| Package | 30 TABLET in 1 BOTTLE (70954-159-30) |
| Marketing Start Date | 2023-08-24 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.708 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CLORAZEPATE 3.75 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis